🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

9 recruiting trials

for Active Moderate to Severe Rheumatoid Arthritis

A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis NCT07276581Phase 2147 sites📍 Glendale📍 Prescott Valley📍 Tucson AstraZeneca · Tests: AZD1163, Placebo The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection NCT07001956EARLY Phase 11 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: UTAA91 injection Korean Post-marketing Surveillance for Xeljanz XR NCT04876781n/a1 site📍 Seoul Pfizer · Tests: Tofacitinib XR A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis NCT06972446Phase 296 sites📍 Peoria📍 Jonesboro📍 Beverly Hills AbbVie · Tests: Lutikizumab, Placebo, Ravagalimab Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis NCT07207954Phase 110 sites📍 Melbourne📍 Tbilisi📍 Chisinau Lifordi Immunotherapeutics, Inc. · Tests: LFD-200, Placebo, Oral Prednisone, Placebo Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis NCT07408024Phase 21 site📍 Beijing Toll Biotech Co. Ltd. (Beijing) · Tests: TollB-001, Placebo Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With Tofacitinib and Statins vs TNF Inhibitors: TOFSTAT CLINICAL TRIAL NCT07554820Phase 41 site📍 Lahore Shaikh Zayed Hospital, Lahore · Tests: Tofacitinib 5 MG A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease NCT07041099Phase 114 sites📍 Orlando📍 Brooklyn📍 Memphis Cullinan Therapeutics Inc. · Tests: CLN-978 Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severely Active RA Who Have an Inadequate Response to at Least One DMARD NCT07423533Phase 21 site📍 Beijing Changchun GeneScience Pharmaceutical Co., Ltd. · Tests: GenSci120 150 mg, GenSci120 600 mg, GenSci120 1000 mg, adalimumab injection 40 mg, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy